NovaBay Pharmaceuticals Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
NovaBay Pharma (NBY) Reports Q3 Loss of $0.11, Revenues Miss
November 14, 2018 4:13 PM ESTNovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.11), versus $0.00 reported last year. Revenue for the quarter came in at $3.14 million versus the consensus estimate of $3.83 million.
We achieved quarterly revenue growth on a sequential basis, as anticipated, driven primarily by deploying sales representatives to territories weve identified... More
